Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-07

AUTHORS

M Chang, SC Raimondi, Y Ravindranath, AJ Carroll, B Camitta, MV Gresik, CP Steuber, H Weinstein

ABSTRACT

The purpose of the paper was to define clinical or biological features associated with the risk for treatment failure for children with acute myeloid leukemia. Data from 560 children and adolescents with newly diagnosed acute myeloid leukemia who entered the Pediatric Oncology Group Study 8821 from June 1988 to March 1993 were analyzed by univariate and recursive partitioning methods. Children with Down syndrome or acute promyelocytic leukemia were excluded from the study. Factors examined included age, number of leukocytes, sex, FAB morphologic subtype, cytogenetic findings, and extramedullary disease at the time of diagnosis. The overall event-free survival (EFS) rate at 4 years was 32.7% (s.e. = 2.2%). Age > or =2 years, fewer than 50 x 10(9)/I leukocytes, and t(8;21) or inv(16), and normal chromosomes were associated with higher rates of EFS (P value = 0.003, 0.049, 0.0003, 0.031, respectively), whereas the M5 subtype of AML (P value = 0.0003) and chromosome abnormalities other than t(8;21) and inv(16) were associated with lower rates of EFS (P value = 0.0001). Recursive partitioning analysis defined three groups of patients with widely varied prognoses: female patients with t(8;21), inv(16), or a normal karyotype (n = 89) had the best prognosis (4-year EFS = 55.1%, s.e. = 5.7%); male patients with t(8;21), inv(16) or normal chromosomes (n = 106) had an intermediate prognosis (4-year EFS = 38.1%, s.e. = 5.3%); patients with chromosome abnormalities other than t(8;21) and inv(16) (n = 233) had the worst prognosis (4-year EFS = 27.0%, s.e. = 3.2%). One hundred and thirty-two patients (24%) could not be grouped because of missing cytogenetic data, mainly due to inadequate marrow samples. The results suggest that pediatric patients with acute myeloid leukemia can be categorized into three potential risk groups for prognosis and that differences in sex and chromosomal abnormalities are associated with differences in estimates of EFS. These results are tentative and must be confirmed by a large prospective clinical trial. More... »

PAGES

1201

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.leu.2401832

DOI

http://dx.doi.org/10.1038/sj.leu.2401832

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1019434822

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10914543


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Azacitidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Aberrations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Inversion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosomes, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytarabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Life Tables", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multicenter Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thioguanine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Translocation, Genetic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Florida", 
          "id": "https://www.grid.ac/institutes/grid.15276.37", 
          "name": [
            "Pediatric Oncology Group Statistical Office, University of Florida, Gainesville, Florida, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chang", 
        "givenName": "M", 
        "id": "sg:person.013142342372.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013142342372.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "St Jude Children's Research Hospital, Memphis, Tennessee, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raimondi", 
        "givenName": "SC", 
        "id": "sg:person.07717571264.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07717571264.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wayne State University", 
          "id": "https://www.grid.ac/institutes/grid.254444.7", 
          "name": [
            "Barbara Ann Karmanos Cancer Institute and Wayne State University, Detroit, Michigan, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ravindranath", 
        "givenName": "Y", 
        "id": "sg:person.01060351400.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060351400.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Alabama at Birmingham", 
          "id": "https://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Human Genetics, University of Alabama at Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carroll", 
        "givenName": "AJ", 
        "id": "sg:person.01175752651.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175752651.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Children's Hospital of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.414086.f", 
          "name": [
            "Midwest Children's Hospital, Milwaukee, Wisconsin, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Camitta", 
        "givenName": "B", 
        "id": "sg:person.016072551517.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016072551517.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Baylor College of Medicine, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gresik", 
        "givenName": "MV", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Baylor College of Medicine, Houston, Texas, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Steuber", 
        "givenName": "CP", 
        "id": "sg:person.01317670032.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317670032.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weinstein", 
        "givenName": "H", 
        "id": "sg:person.01233032233.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233032233.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-1-4612-4380-9_37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007048162", 
          "https://doi.org/10.1007/978-1-4612-4380-9_37"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199501263320403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007194631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018882653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018882653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199605303342203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019019189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020816880", 
          "https://doi.org/10.1038/sj.leu.2401508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020816880", 
          "https://doi.org/10.1038/sj.leu.2401508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.95.18.10860", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030002472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-9473(86)90033-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030512955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199909303411407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040310768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074481979", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074553961", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076061368", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077068234", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077278330", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.2.247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077979515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.4.572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078193751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078440483", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079589299", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081834140", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082422019", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082488739", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.8.1448", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082762674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.1.18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082858551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082878892", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082895213", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083076536", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083196326", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083321512", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-07", 
    "datePublishedReg": "2000-07-01", 
    "description": "The purpose of the paper was to define clinical or biological features associated with the risk for treatment failure for children with acute myeloid leukemia. Data from 560 children and adolescents with newly diagnosed acute myeloid leukemia who entered the Pediatric Oncology Group Study 8821 from June 1988 to March 1993 were analyzed by univariate and recursive partitioning methods. Children with Down syndrome or acute promyelocytic leukemia were excluded from the study. Factors examined included age, number of leukocytes, sex, FAB morphologic subtype, cytogenetic findings, and extramedullary disease at the time of diagnosis. The overall event-free survival (EFS) rate at 4 years was 32.7% (s.e. = 2.2%). Age > or =2 years, fewer than 50 x 10(9)/I leukocytes, and t(8;21) or inv(16), and normal chromosomes were associated with higher rates of EFS (P value = 0.003, 0.049, 0.0003, 0.031, respectively), whereas the M5 subtype of AML (P value = 0.0003) and chromosome abnormalities other than t(8;21) and inv(16) were associated with lower rates of EFS (P value = 0.0001). Recursive partitioning analysis defined three groups of patients with widely varied prognoses: female patients with t(8;21), inv(16), or a normal karyotype (n = 89) had the best prognosis (4-year EFS = 55.1%, s.e. = 5.7%); male patients with t(8;21), inv(16) or normal chromosomes (n = 106) had an intermediate prognosis (4-year EFS = 38.1%, s.e. = 5.3%); patients with chromosome abnormalities other than t(8;21) and inv(16) (n = 233) had the worst prognosis (4-year EFS = 27.0%, s.e. = 3.2%). One hundred and thirty-two patients (24%) could not be grouped because of missing cytogenetic data, mainly due to inadequate marrow samples. The results suggest that pediatric patients with acute myeloid leukemia can be categorized into three potential risk groups for prognosis and that differences in sex and chromosomal abnormalities are associated with differences in estimates of EFS. These results are tentative and must be confirmed by a large prospective clinical trial.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.leu.2401832", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2693343", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693338", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693333", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693331", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693295", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438833", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693349", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693162", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693341", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2693527", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821", 
    "pagination": "1201", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5c99ba19e0ea528a47968aaf31f32030b083631f46dd5daa1a74837a1b076676"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10914543"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8704895"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.leu.2401832"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1019434822"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.leu.2401832", 
      "https://app.dimensions.ai/details/publication/pub.1019434822"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29182_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/2401832"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401832'


 

This table displays all metadata directly associated to this object as RDF triples.

362 TRIPLES      21 PREDICATES      91 URIs      55 LITERALS      43 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.leu.2401832 schema:about N0832344fe4144a65bf1f3d944fce4cb7
2 N0c5f5f4386c44b54a90d7d8dca2c7662
3 N1cad447c23124dba9f3025bbcb45e6cf
4 N1da86e9725df4c0995358470e2462304
5 N292cf30403ba41e19d7bc2671e6fa774
6 N2c0e2afa24b9490eaa2fc484a9282c7f
7 N2d3df775c07a4bdda036d8f7932aa8af
8 N2d8e918d2ee443ec96048c9484ccf6a6
9 N4b462b67c1364f3f93242a926d9c84fb
10 N50edb1d2e7a94dc484e02a5c1d117061
11 N51be42998edb479e9b4c96f06c26f5c4
12 N5324116d77224c298b543de58358a569
13 N59fac5572b5340a189542f5331a26a22
14 N61400302ca5140688b433ceff3f30fb2
15 N6f12c59961614e539d3681b3d70e30a9
16 N757286c0f9e0465da620c3f2d3859604
17 N7889a7b795384713b6cecf203b56d4f5
18 N7c6dd27f4ef04443a035097d449d245f
19 N7e9e315718dc4dfd9e153443365337d3
20 N7f18fa2eff2944a7bcb45f58ee18f044
21 N82a6dedb86e14ef5b509d8567498e504
22 N8be055687610434dbb07d71c7c5d89d5
23 Na84394ed16ee477e8697e19a3baba42b
24 Nbdeffe7c7f484b5eb3c256b82bf6ab67
25 Nbfd1a6d5e86944c7aaf82e67d13e5dff
26 Ncc0ce41801464dd6a4e9b40cafc5e485
27 Nd8ac3d093d63404f8a1620bfc3d2d926
28 Nd8dea190986f4eddb05665655eda2069
29 Nda04b4a900694849b086028ca763209e
30 Ne41b0165059d4014a1b9dd686845451b
31 Ne51da850f32a4828bc9bef7041712336
32 Nf396a7703a634c6ab607e3811cb16f7b
33 Nf89959e9f13941be93defae74ec32494
34 Nfc688184ac094261a732c323a0c2f1ed
35 anzsrc-for:11
36 anzsrc-for:1112
37 schema:author Nf40434e860034adea30a41652b19b3a7
38 schema:citation sg:pub.10.1007/978-1-4612-4380-9_37
39 sg:pub.10.1038/sj.leu.2401508
40 https://app.dimensions.ai/details/publication/pub.1074481979
41 https://app.dimensions.ai/details/publication/pub.1074553961
42 https://app.dimensions.ai/details/publication/pub.1076061368
43 https://app.dimensions.ai/details/publication/pub.1077068234
44 https://app.dimensions.ai/details/publication/pub.1077278330
45 https://app.dimensions.ai/details/publication/pub.1078440483
46 https://app.dimensions.ai/details/publication/pub.1079589299
47 https://app.dimensions.ai/details/publication/pub.1081834140
48 https://app.dimensions.ai/details/publication/pub.1082422019
49 https://app.dimensions.ai/details/publication/pub.1082488739
50 https://app.dimensions.ai/details/publication/pub.1082878892
51 https://app.dimensions.ai/details/publication/pub.1082895213
52 https://app.dimensions.ai/details/publication/pub.1083076536
53 https://app.dimensions.ai/details/publication/pub.1083196326
54 https://app.dimensions.ai/details/publication/pub.1083321512
55 https://doi.org/10.1016/0167-9473(86)90033-2
56 https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x
57 https://doi.org/10.1056/nejm199501263320403
58 https://doi.org/10.1056/nejm199605303342203
59 https://doi.org/10.1056/nejm199909303411407
60 https://doi.org/10.1073/pnas.95.18.10860
61 https://doi.org/10.1080/01621459.1958.10501452
62 https://doi.org/10.1200/jco.1991.9.2.247
63 https://doi.org/10.1200/jco.1991.9.4.572
64 https://doi.org/10.1200/jco.1993.11.8.1448
65 https://doi.org/10.1200/jco.1996.14.1.18
66 schema:datePublished 2000-07
67 schema:datePublishedReg 2000-07-01
68 schema:description The purpose of the paper was to define clinical or biological features associated with the risk for treatment failure for children with acute myeloid leukemia. Data from 560 children and adolescents with newly diagnosed acute myeloid leukemia who entered the Pediatric Oncology Group Study 8821 from June 1988 to March 1993 were analyzed by univariate and recursive partitioning methods. Children with Down syndrome or acute promyelocytic leukemia were excluded from the study. Factors examined included age, number of leukocytes, sex, FAB morphologic subtype, cytogenetic findings, and extramedullary disease at the time of diagnosis. The overall event-free survival (EFS) rate at 4 years was 32.7% (s.e. = 2.2%). Age > or =2 years, fewer than 50 x 10(9)/I leukocytes, and t(8;21) or inv(16), and normal chromosomes were associated with higher rates of EFS (P value = 0.003, 0.049, 0.0003, 0.031, respectively), whereas the M5 subtype of AML (P value = 0.0003) and chromosome abnormalities other than t(8;21) and inv(16) were associated with lower rates of EFS (P value = 0.0001). Recursive partitioning analysis defined three groups of patients with widely varied prognoses: female patients with t(8;21), inv(16), or a normal karyotype (n = 89) had the best prognosis (4-year EFS = 55.1%, s.e. = 5.7%); male patients with t(8;21), inv(16) or normal chromosomes (n = 106) had an intermediate prognosis (4-year EFS = 38.1%, s.e. = 5.3%); patients with chromosome abnormalities other than t(8;21) and inv(16) (n = 233) had the worst prognosis (4-year EFS = 27.0%, s.e. = 3.2%). One hundred and thirty-two patients (24%) could not be grouped because of missing cytogenetic data, mainly due to inadequate marrow samples. The results suggest that pediatric patients with acute myeloid leukemia can be categorized into three potential risk groups for prognosis and that differences in sex and chromosomal abnormalities are associated with differences in estimates of EFS. These results are tentative and must be confirmed by a large prospective clinical trial.
69 schema:genre research_article
70 schema:inLanguage en
71 schema:isAccessibleForFree true
72 schema:isPartOf N89b87e9a522c45768e29425339031cac
73 Ned7c0e4dd4dc46158e4bd998fafac3f7
74 sg:journal.1097065
75 schema:name Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821
76 schema:pagination 1201
77 schema:productId N1125532d0b8647feb7e4d1dde3a05377
78 Na1557731e51d4200aa776368b37f5aac
79 Nbb6bdbbe14ca42cc93ef98864ee0336a
80 Ne190c302dc424b4d86c5f597a16128b5
81 Ne74ca2bd6fd64109b32dc2fddef5350d
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019434822
83 https://doi.org/10.1038/sj.leu.2401832
84 schema:sdDatePublished 2019-04-11T11:50
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher Ne6c5a8fc58aa48118d1fad9eac82f152
87 schema:url https://www.nature.com/articles/2401832
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N0832344fe4144a65bf1f3d944fce4cb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Treatment Outcome
93 rdf:type schema:DefinedTerm
94 N0c5f5f4386c44b54a90d7d8dca2c7662 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Adolescent
96 rdf:type schema:DefinedTerm
97 N1125532d0b8647feb7e4d1dde3a05377 schema:name dimensions_id
98 schema:value pub.1019434822
99 rdf:type schema:PropertyValue
100 N1cad447c23124dba9f3025bbcb45e6cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Combined Modality Therapy
102 rdf:type schema:DefinedTerm
103 N1da86e9725df4c0995358470e2462304 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Translocation, Genetic
105 rdf:type schema:DefinedTerm
106 N292cf30403ba41e19d7bc2671e6fa774 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Etoposide
108 rdf:type schema:DefinedTerm
109 N2a67e0a0ed2b4c9d985a82f2c559a1bd rdf:first sg:person.01060351400.12
110 rdf:rest Nbbedf1cc27904b729b77b1e9c47b6aca
111 N2c0e2afa24b9490eaa2fc484a9282c7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Chromosome Aberrations
113 rdf:type schema:DefinedTerm
114 N2d3df775c07a4bdda036d8f7932aa8af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Treatment Failure
116 rdf:type schema:DefinedTerm
117 N2d8e918d2ee443ec96048c9484ccf6a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N2e5f2ec2cc6e477bbfeabdd95ba2e3c2 rdf:first sg:person.01317670032.09
121 rdf:rest N99b42da5df3a4802b1eeab7ac12a66b7
122 N39061a67cf7041068097509eef32e74b rdf:first sg:person.07717571264.67
123 rdf:rest N2a67e0a0ed2b4c9d985a82f2c559a1bd
124 N4b462b67c1364f3f93242a926d9c84fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 N50edb1d2e7a94dc484e02a5c1d117061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Bone Marrow Transplantation
129 rdf:type schema:DefinedTerm
130 N51be42998edb479e9b4c96f06c26f5c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Multicenter Studies as Topic
132 rdf:type schema:DefinedTerm
133 N5324116d77224c298b543de58358a569 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Proportional Hazards Models
135 rdf:type schema:DefinedTerm
136 N59fac5572b5340a189542f5331a26a22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Azacitidine
138 rdf:type schema:DefinedTerm
139 N61400302ca5140688b433ceff3f30fb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Leukemia, Myeloid
141 rdf:type schema:DefinedTerm
142 N6f12c59961614e539d3681b3d70e30a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Disease-Free Survival
144 rdf:type schema:DefinedTerm
145 N74d471a80cb9441e87e2b9472df5a78e rdf:first N77c06197df7e4125b49c5de7db1d568b
146 rdf:rest N2e5f2ec2cc6e477bbfeabdd95ba2e3c2
147 N757286c0f9e0465da620c3f2d3859604 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Risk Factors
149 rdf:type schema:DefinedTerm
150 N77c06197df7e4125b49c5de7db1d568b schema:affiliation https://www.grid.ac/institutes/grid.39382.33
151 schema:familyName Gresik
152 schema:givenName MV
153 rdf:type schema:Person
154 N7889a7b795384713b6cecf203b56d4f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Antineoplastic Combined Chemotherapy Protocols
156 rdf:type schema:DefinedTerm
157 N7c6dd27f4ef04443a035097d449d245f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Analysis of Variance
159 rdf:type schema:DefinedTerm
160 N7e9e315718dc4dfd9e153443365337d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Survival Analysis
162 rdf:type schema:DefinedTerm
163 N7f18fa2eff2944a7bcb45f58ee18f044 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Cohort Studies
165 rdf:type schema:DefinedTerm
166 N82a6dedb86e14ef5b509d8567498e504 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Doxorubicin
168 rdf:type schema:DefinedTerm
169 N89b87e9a522c45768e29425339031cac schema:volumeNumber 14
170 rdf:type schema:PublicationVolume
171 N8be055687610434dbb07d71c7c5d89d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Prognosis
173 rdf:type schema:DefinedTerm
174 N99b42da5df3a4802b1eeab7ac12a66b7 rdf:first sg:person.01233032233.44
175 rdf:rest rdf:nil
176 Na1557731e51d4200aa776368b37f5aac schema:name pubmed_id
177 schema:value 10914543
178 rdf:type schema:PropertyValue
179 Na84394ed16ee477e8697e19a3baba42b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Cytarabine
181 rdf:type schema:DefinedTerm
182 Nbb6bdbbe14ca42cc93ef98864ee0336a schema:name nlm_unique_id
183 schema:value 8704895
184 rdf:type schema:PropertyValue
185 Nbbedf1cc27904b729b77b1e9c47b6aca rdf:first sg:person.01175752651.98
186 rdf:rest Nd75d91791d704d32bcb23c8903600383
187 Nbdeffe7c7f484b5eb3c256b82bf6ab67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Child
189 rdf:type schema:DefinedTerm
190 Nbfd1a6d5e86944c7aaf82e67d13e5dff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Randomized Controlled Trials as Topic
192 rdf:type schema:DefinedTerm
193 Ncc0ce41801464dd6a4e9b40cafc5e485 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Female
195 rdf:type schema:DefinedTerm
196 Nd75d91791d704d32bcb23c8903600383 rdf:first sg:person.016072551517.65
197 rdf:rest N74d471a80cb9441e87e2b9472df5a78e
198 Nd8ac3d093d63404f8a1620bfc3d2d926 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name United States
200 rdf:type schema:DefinedTerm
201 Nd8dea190986f4eddb05665655eda2069 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Chromosomes, Human
203 rdf:type schema:DefinedTerm
204 Nda04b4a900694849b086028ca763209e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Thioguanine
206 rdf:type schema:DefinedTerm
207 Ne190c302dc424b4d86c5f597a16128b5 schema:name readcube_id
208 schema:value 5c99ba19e0ea528a47968aaf31f32030b083631f46dd5daa1a74837a1b076676
209 rdf:type schema:PropertyValue
210 Ne41b0165059d4014a1b9dd686845451b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Remission Induction
212 rdf:type schema:DefinedTerm
213 Ne51da850f32a4828bc9bef7041712336 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Risk Assessment
215 rdf:type schema:DefinedTerm
216 Ne6c5a8fc58aa48118d1fad9eac82f152 schema:name Springer Nature - SN SciGraph project
217 rdf:type schema:Organization
218 Ne74ca2bd6fd64109b32dc2fddef5350d schema:name doi
219 schema:value 10.1038/sj.leu.2401832
220 rdf:type schema:PropertyValue
221 Ned7c0e4dd4dc46158e4bd998fafac3f7 schema:issueNumber 7
222 rdf:type schema:PublicationIssue
223 Nf396a7703a634c6ab607e3811cb16f7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Chromosome Inversion
225 rdf:type schema:DefinedTerm
226 Nf40434e860034adea30a41652b19b3a7 rdf:first sg:person.013142342372.25
227 rdf:rest N39061a67cf7041068097509eef32e74b
228 Nf89959e9f13941be93defae74ec32494 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Follow-Up Studies
230 rdf:type schema:DefinedTerm
231 Nfc688184ac094261a732c323a0c2f1ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
232 schema:name Life Tables
233 rdf:type schema:DefinedTerm
234 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
235 schema:name Medical and Health Sciences
236 rdf:type schema:DefinedTerm
237 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
238 schema:name Oncology and Carcinogenesis
239 rdf:type schema:DefinedTerm
240 sg:grant.2438833 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
241 rdf:type schema:MonetaryGrant
242 sg:grant.2693162 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
243 rdf:type schema:MonetaryGrant
244 sg:grant.2693295 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
245 rdf:type schema:MonetaryGrant
246 sg:grant.2693331 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
247 rdf:type schema:MonetaryGrant
248 sg:grant.2693333 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
249 rdf:type schema:MonetaryGrant
250 sg:grant.2693338 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
251 rdf:type schema:MonetaryGrant
252 sg:grant.2693341 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
253 rdf:type schema:MonetaryGrant
254 sg:grant.2693343 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
255 rdf:type schema:MonetaryGrant
256 sg:grant.2693349 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
257 rdf:type schema:MonetaryGrant
258 sg:grant.2693527 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.leu.2401832
259 rdf:type schema:MonetaryGrant
260 sg:journal.1097065 schema:issn 0887-6924
261 1476-5551
262 schema:name Leukemia
263 rdf:type schema:Periodical
264 sg:person.01060351400.12 schema:affiliation https://www.grid.ac/institutes/grid.254444.7
265 schema:familyName Ravindranath
266 schema:givenName Y
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060351400.12
268 rdf:type schema:Person
269 sg:person.01175752651.98 schema:affiliation https://www.grid.ac/institutes/grid.265892.2
270 schema:familyName Carroll
271 schema:givenName AJ
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175752651.98
273 rdf:type schema:Person
274 sg:person.01233032233.44 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
275 schema:familyName Weinstein
276 schema:givenName H
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233032233.44
278 rdf:type schema:Person
279 sg:person.013142342372.25 schema:affiliation https://www.grid.ac/institutes/grid.15276.37
280 schema:familyName Chang
281 schema:givenName M
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013142342372.25
283 rdf:type schema:Person
284 sg:person.01317670032.09 schema:affiliation https://www.grid.ac/institutes/grid.39382.33
285 schema:familyName Steuber
286 schema:givenName CP
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317670032.09
288 rdf:type schema:Person
289 sg:person.016072551517.65 schema:affiliation https://www.grid.ac/institutes/grid.414086.f
290 schema:familyName Camitta
291 schema:givenName B
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016072551517.65
293 rdf:type schema:Person
294 sg:person.07717571264.67 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
295 schema:familyName Raimondi
296 schema:givenName SC
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07717571264.67
298 rdf:type schema:Person
299 sg:pub.10.1007/978-1-4612-4380-9_37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007048162
300 https://doi.org/10.1007/978-1-4612-4380-9_37
301 rdf:type schema:CreativeWork
302 sg:pub.10.1038/sj.leu.2401508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020816880
303 https://doi.org/10.1038/sj.leu.2401508
304 rdf:type schema:CreativeWork
305 https://app.dimensions.ai/details/publication/pub.1074481979 schema:CreativeWork
306 https://app.dimensions.ai/details/publication/pub.1074553961 schema:CreativeWork
307 https://app.dimensions.ai/details/publication/pub.1076061368 schema:CreativeWork
308 https://app.dimensions.ai/details/publication/pub.1077068234 schema:CreativeWork
309 https://app.dimensions.ai/details/publication/pub.1077278330 schema:CreativeWork
310 https://app.dimensions.ai/details/publication/pub.1078440483 schema:CreativeWork
311 https://app.dimensions.ai/details/publication/pub.1079589299 schema:CreativeWork
312 https://app.dimensions.ai/details/publication/pub.1081834140 schema:CreativeWork
313 https://app.dimensions.ai/details/publication/pub.1082422019 schema:CreativeWork
314 https://app.dimensions.ai/details/publication/pub.1082488739 schema:CreativeWork
315 https://app.dimensions.ai/details/publication/pub.1082878892 schema:CreativeWork
316 https://app.dimensions.ai/details/publication/pub.1082895213 schema:CreativeWork
317 https://app.dimensions.ai/details/publication/pub.1083076536 schema:CreativeWork
318 https://app.dimensions.ai/details/publication/pub.1083196326 schema:CreativeWork
319 https://app.dimensions.ai/details/publication/pub.1083321512 schema:CreativeWork
320 https://doi.org/10.1016/0167-9473(86)90033-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030512955
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1046/j.1365-2141.1996.d01-1761.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018882653
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1056/nejm199501263320403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007194631
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1056/nejm199605303342203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019019189
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1056/nejm199909303411407 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040310768
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1073/pnas.95.18.10860 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030002472
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1200/jco.1991.9.2.247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077979515
335 rdf:type schema:CreativeWork
336 https://doi.org/10.1200/jco.1991.9.4.572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078193751
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1200/jco.1993.11.8.1448 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082762674
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1200/jco.1996.14.1.18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082858551
341 rdf:type schema:CreativeWork
342 https://www.grid.ac/institutes/grid.15276.37 schema:alternateName University of Florida
343 schema:name Pediatric Oncology Group Statistical Office, University of Florida, Gainesville, Florida, USA
344 rdf:type schema:Organization
345 https://www.grid.ac/institutes/grid.240871.8 schema:alternateName St. Jude Children's Research Hospital
346 schema:name St Jude Children's Research Hospital, Memphis, Tennessee, USA
347 rdf:type schema:Organization
348 https://www.grid.ac/institutes/grid.254444.7 schema:alternateName Wayne State University
349 schema:name Barbara Ann Karmanos Cancer Institute and Wayne State University, Detroit, Michigan, USA
350 rdf:type schema:Organization
351 https://www.grid.ac/institutes/grid.265892.2 schema:alternateName University of Alabama at Birmingham
352 schema:name Department of Human Genetics, University of Alabama at Birmingham, Alabama, USA
353 rdf:type schema:Organization
354 https://www.grid.ac/institutes/grid.32224.35 schema:alternateName Massachusetts General Hospital
355 schema:name Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
356 rdf:type schema:Organization
357 https://www.grid.ac/institutes/grid.39382.33 schema:alternateName Baylor College of Medicine
358 schema:name Baylor College of Medicine, Houston, Texas, USA
359 rdf:type schema:Organization
360 https://www.grid.ac/institutes/grid.414086.f schema:alternateName Children's Hospital of Wisconsin
361 schema:name Midwest Children's Hospital, Milwaukee, Wisconsin, USA
362 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...